Last reviewed · How we verify
NCT05999032: PR-AIR
The Puerto Rico Asthma Integrated Response Program ("PR-AIR")
NA trial testing CASE in person version (High Intensity Package) in Pediatric Asthma in 480 participants. Currently enrolling.
30 November 2026
Quick facts
| Lead sponsor | Rhode Island Hospital |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 480 |
| Start date | 16 December 2024 |
| Primary completion | 30 November 2026 |
| Estimated completion | 31 July 2027 |
| Sites | 2 locations across Puerto Rico, United States |
Drugs / interventions tested
- CASE in person version (High Intensity Package)
- CASE-V remote version (Low Intensity Package)
- CASE and HARP in person (High Intensity package)
- CASE-V and HARP-V remote version (Low Intensity package)
Conditions studied
- Pediatric Asthma — all drugs for Pediatric Asthma →
Sponsor
Rhode Island Hospital
Who can join
Adults 2 to 12, any sex, with Pediatric Asthma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to adapt and deliver an evidence-based multi-level intervention to reduce asthma disparities, and that promote and improve population health in the high-burden communities of San Juan, Puerto Rico. The Puerto Rico-Asthma Integrated Response Program (PR-AIR) will be implemented and evaluated to address pediatric asthma disparities in San Juan, PR, an area of high asthma burden. This study unfolds in two phases: In Phase 1, the researchers will collaborate with community stakeholders to identify needs, barriers and facilitators of PR-AIR implementation. Phase 2 consists of an evaluation of low-intensity (virtual) and high-intensity (in-person) methods of PR-AIR implementation outcomes using the RE-AIM (Reach, Effectiveness, Adoption, Implementation, and Maintenance) framework and a mixed methods approach.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05999032
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pediatric Asthma
Currently open trials in the same condition.
- NCT07381790 — Modern Technologies in Lower Respiratory Tract Infections in Children · recruiting
- NCT06903897 — Social Needs Screening and Chronic Diseases Study (WE CARE) · NA · recruiting
- NCT07500532 — Evaluation of the Medentum Diagnostik Platform for Pediatric ENT Conditions and Asthma · NA · recruiting
- NCT05945355 — Mechanistic Study of Inspiratory Training in Childhood Asthma (MICA) · NA · recruiting
- NCT06535087 — The Impact of Airway Allergic Diseases on Children's and Parents' Quality of Life · recruiting
Other Rhode Island Hospital trials
Trials by the same sponsor.
- NCT06747221 — Implementation Science to Enhance HIV Testing Services During Emergency Care in Kenya · NA · not yet recruiting
- NCT07211087 — Improving the Treatment of Depression Among Youth With HIV · NA · not yet recruiting
- NCT06754527 — Options for Navigating Talking About Risk and Adolescent Choices · NA · not yet recruiting
- NCT07144631 — Peroneal Electrical Nerve Stimulation in Pregnancy for Restless Legs Syndrome · NA · recruiting
- NCT06942455 — A Sleep Hygiene Intervention to Improve Sleep Health in Urban, Latino Middle School Children · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05999032 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Rhode Island Hospital
- Last refreshed: 20 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05999032.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing